Using a combination of subcellular proteomics and in vivo analyses, we revealed that Prrx1 potentiates stemness and vessels formation in glioma by activating the TGF-β/smad pathway and upregulating stemness-related genes and proangiogenic factors (Fig. 8). This evidence concerns the gene PRRX1 and central nervous system cancer.